AAPG Competitors & Alternatives
Compare Ascentage Pharma Group International with similar stocks in the same industry
Biotechnology
AAPG
Main Stock$19.10
Tradestie Score
46
Market Cap
$3.68B
Revenue Growth
1.2%
Analyst Upside
+149.0%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$37.17
|
$1.84B | - | 47 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$34.48
|
$1.81B | - | 56 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.97
|
$1.78B | - | 54 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$23.83
|
$1.78B | - | 56 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$19.18
|
$1.74B | - | 56 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$35.66
|
$1.68B | - | 52 | Compare |
|
MNKD
Mannkind Corporation
|
$4.05
|
$1.65B | - | 53 | Compare |
|
MPLT
MPLT
|
$37.44
|
$1.63B | - | 57 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$39.58
|
$1.63B | - | 47 | Compare |
|
BHVN
Biohaven Ltd.
|
$15.51
|
$1.57B | - | 52 | Compare |
More AAPG Analysis
Data updated: Jul 21, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry